GBM treatment disparities chart, most in our survey were not offered a clinical trial

At the GBM Drug Development Summit? Stop by our poster, meet Executive Director Kelli Duprey, and learn about how people in the USA are being treated — most were not offered a chance to participate in a clinical trial.

#GBMSummit #GBMDisparities #GBM #glioblastoma

Vigeo Therapeutics to Present at the 2024 Glioblastoma Drug Development Summit in Boston Massachusetts - Vigeo Cambridge MA – March 26, 2024 –Vigeo Therapeutics, a clinical-stage immuno-therapy company pioneering novel therapies to treat oncology and inflammatory diseases will be presenting at the Fifth Gliobl...

Don't miss the #VT1021 update from @vigeotx.bsky.social COO Jing Watnick at the #GBMSummit in Boston MA this week. Dr. Watnick will give an update on the #VT1021 Ph1/2 program in #GBM as well as potential future use of #VT1021 in Neuro-inflammatory disease #glioblastoma #neuroinflammatorydisease